Related Experiment Video
Updated: Jun 3, 2026

10:01
Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
Published on: July 10, 2012
Pneumothorax derived from bronchiolitis obliterans after marrow transplantation
Sumitaka Yamanaka1, Taketsugu Yamamoto, Kenji Inui
1Department of Thoracic Surgery, Yokohama City University Medical Center, Yokohama, Japan. syamana1@jhmi.edu
Asian Cardiovascular & Thoracic Annals
|April 8, 2011
Summary
Bronchiolitis obliterans, a severe lung disease after bone marrow transplant, can cause rare bilateral pneumothorax. Extensive thoracolysis offered an effective acute treatment for this life-threatening complication.
Area of Science:
- Pulmonary Medicine
- Hematology
- Transplantation Immunology
Background:
- Long-term survival post-bone marrow transplantation (BMT) is increasing.
- Chronic graft-versus-host disease (cGvHD) can lead to serious pulmonary complications.
- Bronchiolitis obliterans (BO) is a critical and often untreatable pulmonary sequela of cGvHD.
Observation:
- Bilateral pneumothorax is an uncommon but serious manifestation associated with bronchiolitis obliterans.
- A 42-year-old male patient presented with intractable pneumothorax following BMT and surgical interventions.
- This clinical scenario highlights the challenges in managing pulmonary complications post-BMT.
Findings:
- Extensive thoracolysis was performed as an acute treatment for the patient's severe pneumothorax.
- The surgical intervention demonstrated effectiveness in managing this rare and life-threatening condition.
- This case suggests thoracolysis as a potential therapeutic option for refractory pneumothorax in BO.
Implications:
- Highlights the need for vigilant monitoring of pulmonary health in BMT survivors.
- Suggests exploring surgical interventions for managing rare pulmonary complications of cGvHD.
- Provides insight into potential treatment strategies for intractable pneumothorax in the context of bronchiolitis obliterans.
Related Concept Videos
Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
Pneumothorax-I
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax II: Pathophysiology
Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
